About the Company
Opiant Pharmaceuticals, Inc., the company that developed NARCAN® Nasal Spray, is building a leading franchise of new medicines to combat addictions and drug overdose.
Fundamental Data and Insider Transactions (Quarterly data) Full Screen
Loading the fundamentals chart...
Latest $OPNT News
Pharmaceutical companies behind weight-loss drugs are slimming down a new target: The Magnificent 7
In today's big story, we're looking at pharma companies' surging stocks and threatening tech darlings thanks to their ...
Buy Rating Justified for Olema Pharmaceuticals Amidst Promising Trial Results and Significant Market Opportunity
Analyst Naureen Quibria of Capital One Financial reiterated a Buy rating on Olema Pharmaceuticals (OLMA – Research Report), with a price ...
TD Cowen Keeps Their Buy Rating on Ionis Pharmaceuticals (IONS)
In a report released today, Yaron Werber from TD Cowen maintained a Buy rating on Ionis Pharmaceuticals (IONS – Research Report). The ...
Marinus Pharmaceuticals: Q4 Earnings Snapshot
The Radnor, Pennsylvania-based company said it had a loss of 74 cents per share. The results did not meet Wall Street expectations. The average estimate of six analysts surveyed by Zacks Investment ...
EyePoint Pharmaceuticals: Q4 Earnings Snapshot
WATERTOWN, Mass. (AP) — WATERTOWN, Mass. (AP) — EyePoint Pharmaceuticals (EYPT) on Thursday reported a loss of $14.1 million in its fourth quarter. On a per-share basis, the Watertown, ...
Loading the latest forecasts...